Published in Am Rev Respir Dis on June 01, 1991
Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med (2013) 3.98
Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med (2004) 2.70
Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc (2008) 2.49
A simplified method for determining phenotypic traits in patients with obstructive sleep apnea. J Appl Physiol (1985) (2013) 2.27
Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest (2007) 1.86
Effect of end-expiratory lung volume on upper airway collapsibility in sleeping men and women. J Appl Physiol (1985) (2010) 1.74
The influence of aging on pharyngeal collapsibility during sleep. Chest (2007) 1.55
Respiratory control stability and upper airway collapsibility in men and women with obstructive sleep apnea. J Appl Physiol (1985) (2005) 1.37
Neural drive to human genioglossus in obstructive sleep apnoea. J Physiol (2007) 1.28
Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea. J Physiol (2012) 1.27
CrossTalk proposal: the human upper airway does behave like a Starling resistor during sleep. J Physiol (2013) 1.25
Sleep. 2: pathophysiology of obstructive sleep apnoea/hypopnoea syndrome. Thorax (2004) 1.24
Diagnostic issues in pediatric obstructive sleep apnea. Proc Am Thorac Soc (2008) 1.24
A nasal cannula can be used to treat obstructive sleep apnea. Am J Respir Crit Care Med (2007) 1.23
Childhood obesity and obstructive sleep apnea syndrome. J Appl Physiol (1985) (2009) 1.22
Obesity and upper airway control during sleep. J Appl Physiol (1985) (2009) 1.21
Influence of head extension, flexion, and rotation on collapsibility of the passive upper airway. Sleep (2008) 1.17
Puberty and upper airway dynamics during sleep. Sleep (2008) 1.09
The effect of increased genioglossus activity and end-expiratory lung volume on pharyngeal collapse. J Appl Physiol (1985) (2010) 1.09
Performance characteristics of upper airway critical collapsing pressure measurements during sleep. Sleep (2011) 1.07
Pathogenesis of obstructive sleep apnoea in hypertensive patients: role of fluid retention and nocturnal rostral fluid shift. J Hum Hypertens (2014) 1.04
Physiologic, metabolic, and muscle fiber type characteristics of musculus uvulae in sleep apnea hypopnea syndrome and in snorers. J Clin Invest (1995) 1.03
Risks of general anaesthesia in people with obstructive sleep apnoea. BMJ (2004) 1.03
Phasic respiratory pharyngeal mechanics by magnetic resonance imaging in lean and obese zucker rats. Am J Respir Crit Care Med (2006) 1.02
A systematic review of the effects of sedatives and anesthetics in patients with obstructive sleep apnea. J Anaesthesiol Clin Pharmacol (2011) 1.00
Mechanical properties of the upper airway. Compr Physiol (2012) 0.96
Upper-airway collapsibility: measurements and sleep effects. Chest (2001) 0.96
The compensatory responses to upper airway obstruction in normal subjects under propofol anesthesia. Respir Physiol Neurobiol (2009) 0.95
Evidence for expiratory flow limitation of extrathoracic origin in patients with obstructive sleep apnoea. Thorax (2002) 0.95
Effect of a high-flow open nasal cannula system on obstructive sleep apnea in children. Pediatrics (2009) 0.93
Effect of age and weight on upper airway function in a mouse model. J Appl Physiol (1985) (2011) 0.92
Operating characteristics of the negative expiratory pressure technique in predicting obstructive sleep apnoea syndrome in snoring patients. Thorax (2004) 0.91
Upper airway mechanics. Respiration (2009) 0.91
The classical Starling resistor model often does not predict inspiratory airflow patterns in the human upper airway. J Appl Physiol (1985) (2014) 0.90
Surgical correction of nasal obstruction in the treatment of mild sleep apnoea: importance of cephalometry in predicting outcome. Thorax (1993) 0.90
A simple procedure for measuring pharyngeal sensitivity: a contribution to the diagnosis of sleep apnoea. Thorax (2005) 0.87
Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment options. Nat Sci Sleep (2010) 0.87
Critical closing pressure during midazolam-induced sleep. J Appl Physiol (1985) (2011) 0.87
Leptin and the control of pharyngeal patency during sleep in severe obesity. J Appl Physiol (1985) (2014) 0.86
Physiology-Based Modeling May Predict Surgical Treatment Outcome for Obstructive Sleep Apnea. J Clin Sleep Med (2017) 0.86
Childhood obesity and obstructive sleep apnea. J Nutr Metab (2012) 0.85
The effect of leptin replacement on sleep-disordered breathing in the leptin-deficient ob/ob mouse. J Appl Physiol (1985) (2015) 0.84
Response to CPAP withdrawal in patients with mild versus severe obstructive sleep apnea/hypopnea syndrome. Sleep (2013) 0.83
Electrical stimulation of the hypoglossal nerve: a potential therapy. J Appl Physiol (1985) (2013) 0.83
Neuromechanical control of the isolated upper airway of mice. J Appl Physiol (1985) (2008) 0.81
Upper Airway Collapsibility (Pcrit) and Pharyngeal Dilator Muscle Activity are Sleep Stage Dependent. Sleep (2016) 0.81
The pathogenesis of obstructive sleep apnea. J Thorac Dis (2015) 0.81
Upper airway dynamics during negative expiratory pressure in apneic and non-apneic awake snorers. Respir Res (2006) 0.81
Obesity and ARDS. Chest (2012) 0.80
Localizing Effects of Leptin on Upper Airway and Respiratory Control during Sleep. Sleep (2016) 0.80
New Approaches to Diagnosing Sleep-Disordered Breathing. Sleep Med Clin (2016) 0.78
Negative Expiratory Pressure Technique: An Awake Test to Measure Upper Airway Collapsibility in Adolescents. Sleep (2015) 0.78
Tailored treatment strategies for obstructive sleep apnea. Respir Investig (2015) 0.78
The influence of nocturnal alcohol ingestion on snoring. Eur Arch Otorhinolaryngol (2009) 0.78
Increased sympathetic and decreased parasympathetic cardiac tone in patients with sleep related alveolar hypoventilation. Sleep (2013) 0.77
Impediment in upper airway stabilizing forces assessed by phrenic nerve stimulation in sleep apnea patients. Respir Res (2005) 0.77
Expiratory Flow Limitation in Obstructive Sleep Apnea and COPD: A Quantitative Method to Detect Pattern Differences Using the Negative Expiratory Pressure Technique. Open Respir Med J (2012) 0.76
The influence of obesity on different genders in patients with obstructive sleep apnea. ScientificWorldJournal (2014) 0.76
Test of the Starling resistor model in the human upper airway during sleep. J Appl Physiol (1985) (2014) 0.76
Approach for streamlining measurement of complex physiological phenotypes of upper airway collapsibility. Comput Biol Med (2013) 0.76
Negative expiratory pressure (NEP) parameters can predict obstructive sleep apnea syndrome in snoring patients. Lung (2008) 0.76
Phasic respiratory modulation of pharyngeal collapsibility via neuromuscular mechanisms in rats. J Appl Physiol (1985) (2011) 0.75
Rebuttal from James P. Butler, Robert L. Owens, Atul Malhotra and Andrew Wellman. J Physiol (2013) 0.75
The Future of Sleep and Circadian Testing. Sleep Med Clin (2009) 0.75
An Examination of Methodological Paradigms for Calculating Upper Airway Critical Pressures during Sleep. Sleep (2016) 0.75
Response to a combination of oxygen and a hypnotic as treatment for obstructive sleep apnoea is predicted by a patient's therapeutic CPAP requirement. Respirology (2017) 0.75
Validation of a measurement to predict upper airway collapsibility during sedation for colonoscopy. J Clin Monit Comput (2012) 0.75
Phenotyping-based treatment improves obstructive sleep apnea symptoms and severity: a pilot study. Sleep Breath (2017) 0.75
A psychomotor stimulant theory of addiction. Psychol Rev (1987) 6.42
Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine. Proc Natl Acad Sci U S A (1978) 6.01
Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis (1993) 5.82
Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature (2001) 5.14
Methods for obtaining and analyzing unattended polysomnography data for a multicenter study. Sleep Heart Health Research Group. Sleep (1998) 4.99
An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep (1997) 4.40
Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis (1992) 4.19
Advanced multiplexed analysis with the FlowMetrix system. Clin Chem (1997) 4.03
The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell (1996) 3.82
Brain swelling in first hour after coronary artery bypass surgery. Lancet (1993) 3.80
Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest (2000) 3.75
The minimal important difference of exercise tests in severe COPD. Eur Respir J (2010) 3.27
Trapping of organic blockers by closing of voltage-dependent K+ channels: evidence for a trap door mechanism of activation gating. J Gen Physiol (1997) 3.13
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
A survey screen for prediction of apnea. Sleep (1995) 2.84
Crypts are the site of intestinal fluid and electrolyte secretion. Science (1982) 2.66
Night-to-night variability in CPAP use over the first three months of treatment. Sleep (1997) 2.56
Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia (1973) 2.48
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Determinants of maximal expiratory flow from the lungs. J Appl Physiol (1967) 2.36
Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest (1995) 2.36
The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. Science (1987) 2.35
Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol (1985) (1988) 2.34
Gastric juice N-nitrosamines in health and gastroduodenal disease. Lancet (1981) 2.29
Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol (1985) (1988) 2.20
Computerized tomography in obstructive sleep apnea. Correlation of airway size with physiology during sleep and wakefulness. Am Rev Respir Dis (1983) 2.18
The alpha(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity (2001) 2.10
Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med (1999) 2.08
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med (1996) 1.96
Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. J Thromb Haemost (2005) 1.92
The hypotonic upper airway in obstructive sleep apnea: role of structures and neuromuscular activity. Am J Respir Crit Care Med (1998) 1.90
Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis (1991) 1.89
Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med (1994) 1.83
Chloride secretion by canine tracheal epithelium: I. Role of intracellular c AMP levels. J Membr Biol (1982) 1.79
Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med (2000) 1.79
Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg (1999) 1.78
Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci (1981) 1.77
Effects of varying approaches for identifying respiratory disturbances on sleep apnea assessment. Am J Respir Crit Care Med (2000) 1.76
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
Chloride secretion by canine tracheal epithelium: II. The cellular electrical potential profile. J Membr Biol (1982) 1.74
Alpha(1,3)-fucosyltransferase VII-dependent synthesis of P- and E-selectin ligands on cultured T lymphoblasts. J Immunol (1998) 1.73
Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest (1993) 1.70
5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res (1998) 1.66
The pharyngeal critical pressure. The whys and hows of using nasal continuous positive airway pressure diagnostically. Chest (1996) 1.66
Physiologic manifestations of human anaphylaxis. J Clin Invest (1980) 1.65
The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol (1988) 1.65
Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) (1984) 1.61
Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food. Science (1978) 1.59
Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum (1992) 1.59
Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA (1985) 1.57
Potent bronchoprotective effect of deep inspiration and its absence in asthma. J Appl Physiol (1985) (2000) 1.56
A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet (1977) 1.55
Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med (1985) 1.55
Mode of action of heat-stable Escherichia coli enterotoxin. Tissue and subcellular specificities and role of cyclic GMP. Biochim Biophys Acta (1980) 1.55
Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci (1996) 1.53
Abbreviated method for assessing upper airway function in obstructive sleep apnea. Chest (2000) 1.52
Myasthenia gravis and upper airway obstruction. Chest (1996) 1.51
Behavioral, attitudinal, and physiologic characteristics of smoking and nonsmoking asbestos-exposed shipyard workers. J Occup Med (1983) 1.50
Risk factors in chronic obstructive pulmonary disease (COPD). Am J Epidemiol (1977) 1.50
Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med (1995) 1.50
Catecholamine effects on cyclic AMP levels and ion secretion in rabbit ileal mucosa. Am J Physiol (1975) 1.50
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med (1994) 1.50
Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science (1975) 1.49
Effect of cimetidine on gastric juice N-nitrosamine concentration. Lancet (1981) 1.49
Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice. J Thromb Haemost (2006) 1.49
Pulmonary function and respiratory chemosensitivity in moderately obese patients with sleep apnea. Chest (1993) 1.49
Ventilating with tracheal gas insufflation and periodic tracheal occlusion during sleep and wakefulness. Chest (2002) 1.48
Leptin, obesity, and respiratory function. Respir Physiol (2000) 1.47
A model of obstructive sleep apnea in normal humans. Role of the upper airway. Am J Respir Crit Care Med (2000) 1.47
Leftward septal displacement during right ventricular loading in man. Circulation (1980) 1.46
Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm Res (1994) 1.45
A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects. Am Rev Respir Dis (1982) 1.44
Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology (Berl) (1976) 1.43
Magnet retained overdentures using the Astra dental implant system. Br Dent J (1993) 1.42
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med (1994) 1.42
Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurons of the ventral tegmental area. J Neurosci (2000) 1.41
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol (1992) 1.41
Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis (1990) 1.40
Room air disinfection by ultraviolet irradiation of upper air. Air mixing and germicidal effectiveness. Arch Environ Health (1971) 1.40
Two step mesoatrial shunt in Budd-Chiari syndrome. Case report. Eur J Surg (1994) 1.40